L Wondrack

2.7k citations

13 papers · 2.2k indexed · 2 hit papers · h-index 10

Impact in

Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Microbiology top 1%
- Bacterial Infections and Vaccines

Papers in

Molecular Medicine 3
- Antibiotic Resistance in Bacteria 3
Biotechnology 2

Co-authors: Joyce A. Sutcliffe Amelia Tait‐Kamradt Fadia B. Dib-Hajj J. P. Clancy Mark R. Cronan Wei Yuan Bingwei Yang Mark A. Massa
Journals: Antimicrobial Agents and Chemotherapy (7 papers)The Journal of Antibiotics (1 paper)Applied Biochemistry and Biotechnology (1 paper)Analytical Biochemistry (1 paper)RNA (1 paper)
Partner nations: United States France

In The Last Decade

L Wondrack

12 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Detection of erythromycin-resistant determinants by PCR 1996 · 866 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1996 Antimicrobial Agents and Chemotherapy
1996 Antimicrobial Agents and Chemotherapy

Peers

Countries citing papers authored by L Wondrack

Since Specialization

Citations

This map shows the geographic impact of L Wondrack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Wondrack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Wondrack more than expected).

Fields of papers citing papers by L Wondrack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Wondrack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Wondrack. The network helps show where L Wondrack may publish in the future.

Co-authors

The 25 scholars most cited alongside L Wondrack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L Wondrack Line = papers co-authored together L Wondrack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	A systematic study of 50S ribosomal subunit purification enabling robust crystallization Acta Crystallographica Section D Biological Crystallography ·Thomas J. McLellan, Eric S. Marr, L Wondrack, Timothy A. Subashi, Paul A. Aeed, Seungil Han, Won‐Wu Lee, Ing-Kae Wang, Bruce A. Maguire	2009	14
2	Purification of the large ribosomal subunit via its association with the small subunit Analytical Biochemistry ·Samuel P. Simons, Thomas J. McLellan, Paul A. Aeed, Richard P. Zaniewski, Charlene Desbonnet, L Wondrack, Eric S. Marr, Timothy A. Subashi, Thomas J. Dougherty, Won‐Wu Lee, Ing-Kae Wang, Peter K. LeMotte, Bruce A. Maguire	2009	6
3	A novel chromatography system to isolate active ribosomes from pathogenic bacteria RNA ·Bruce A. Maguire, L Wondrack, Leonard G. Contillo, Won‐Wu Lee	2007	27
4	Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North America Antimicrobial Agents and Chemotherapy ·Amelia Tait‐Kamradt, Todd A. Davies, Peter C. Appelbaum, Florence Depardieu, Patrice Courvalin, J.W. Petitpas, L Wondrack, Mariana Khatab, Michael R. Jacobs, Joyce A. Sutcliffe	2000	205
5	mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae Antimicrobial Agents and Chemotherapy ·Amelia Tait‐Kamradt, J. P. Clancy, Mark R. Cronan, Fadia B. Dib-Hajj, L Wondrack, Wei Yuan, Joyce A. Sutcliffe	1997	256
6	Detection of erythromycin-resistant determinants by PCR Antimicrobial Agents and Chemotherapy ·Joyce A. Sutcliffe, 圭祐菅野, Amelia Tait‐Kamradt, L Wondrack Hit paper breakdown →	1996	866
7	Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection Antimicrobial Agents and Chemotherapy ·Jay Bergeron, Mark Ammirati, Dennis E. Danley, L James, Hartley Rogersi, James A. Retsema, Christine A. Strick, W.-G. Su, Joyce A. Sutcliffe, L Wondrack	1996	112
8	Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides Antimicrobial Agents and Chemotherapy ·L Wondrack, Mark A. Massa, Bingwei Yang, Joyce A. Sutcliffe	1996	106
9	Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system Antimicrobial Agents and Chemotherapy ·Joyce A. Sutcliffe, Amelia Tait‐Kamradt, L Wondrack Hit paper breakdown →	1996	537
10	CJ-12,371 and CJ-12,372, Two Novel DNA Gyrase Inhibitors. Fermentation, Isolation, Structural Elucidation and Biological Activities. The Journal of Antibiotics ·Shinichi Sakemi, TAISUKE INAGAKI, Kotaro Okayama, Hideo Hirai, Р М Авдеев, TATSUO SAKAKIBARA, Yuji Yamauchi, Hartley Rogersi, L Wondrack, Joyce A. Sutcliffe, Nakao Kojima	1995	46
11	Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes Antimicrobial Agents and Chemotherapy ·Fan Peiran, Amelia Tait‐Kamradt, J.W. Petitpas, MARY MANOUSOS, Paul R. McGuirk, Timothy A. Subashi, 韩思阳, L Wondrack	1994	7
12	Depolymerization of water soluble coal polymer from subbituminous coal and lignite by lignin peroxidase Applied Biochemistry and Biotechnology ·L Wondrack, Т. А. Тихонова, W.A. Wood	1989	62
13	Lignin peroxidase-catalyzed depolymerization of water soluble polymer derived from subbituminous coal and lignite L Wondrack, Т. А. Тихонова, W.A. Wood	1988	0

About L Wondrack

L Wondrack is a scholar working on Molecular Medicine, Biotechnology, Infectious Diseases, Virology and Microbiology, having authored 13 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (4 papers), RNA modifications and cancer (3 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotic Resistance in Bacteria (3 papers), RNA and protein synthesis mechanisms (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Enzyme-mediated dye degradation (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (484 citations), Microbiology (404 citations), Infectious Diseases (1.1k citations), Clinical Biochemistry (244 citations) and Epidemiology (1.1k citations). L Wondrack has collaborated with scholars based in United States and France. Frequent co-authors include Joyce A. Sutcliffe, Amelia Tait‐Kamradt, Fadia B. Dib-Hajj, J. P. Clancy, Mark R. Cronan, Wei Yuan, Bingwei Yang, Mark A. Massa, Patrice Courvalin and Florence Depardieu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Applied Biochemistry and Biotechnology, Analytical Biochemistry and RNA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact